Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic LeukemiaJohn C. Byrd, Richard R. Furman, Bonnie K. Harrington et al.|New England Journal of Medicine|2015Cited by 890
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.William G. Wierda, Hema Sundar, John C. Byrd et al.|PubMed|2020Cited by 143
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019William G. Wierda, Hema Sundar, John C. Byrd et al.|Journal of the National Comprehensive Cancer Network|2019Cited by 94
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022William G. Wierda, Hema Sundar, Jennifer R. Brown et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 84
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024William G. Wierda, Mary A. Dwyer, Jennifer R. Brown et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 83